Low HDL Polygenic Risk Score

Most people think of cholesterol numbers as something that drifts up or down based on diet, weight, and age. But a significant chunk of your HDL (high-density lipoprotein, often called 'good cholesterol') is set by the hand you were dealt at birth: many small DNA variations scattered across the genome that nudge your HDL down. A Low HDL Polygenic Risk Score (PRS) bundles those variations into a single number that estimates your inherited tendency toward low HDL.

This is a genetic test, not a cholesterol measurement. It tells you about the deck you were dealt, not how you are playing the hand right now. That matters because the same lifestyle changes can move different people's HDL by very different amounts, and knowing your genetic baseline helps you set expectations and plan accordingly.

How Genes Shape HDL

HDL particles are built around a protein called apolipoprotein A-I (apoA-I), made by your liver and intestine. These particles pull excess cholesterol out of cells, including the foam cells that build up in artery walls, and shuttle it back to the liver. This process is called reverse cholesterol transport, and it is one of the body's main defenses against artery-clogging plaque.

Many common DNA variants in genes that control HDL production and remodeling (such as CETP, APOA1, ABCA1, and LPL) each have small effects on HDL levels. Carry a few of them and you might not notice. Carry many and your HDL tends to run low across your entire life. In one study of people with extremely low or high HDL, only a small minority carried a single big-effect mutation, while a meaningful fraction had extreme polygenic scores, meaning their extreme HDL came from the cumulative weight of many small variants.

Heart Disease Risk

Low HDL is a well-established risk factor for heart attack and stroke, and the genetics behind low HDL tracks with that risk. In an Israeli cohort of 5,584 adults, people with a high genetic risk score for both low HDL and high triglycerides had substantially higher odds of cardiovascular disease compared to those with low scores, and in some subgroups the odds climbed even higher.

The mechanism is straightforward. Lower HDL means weaker cholesterol cleanup, more cholesterol parked in artery walls, and faster plaque growth. A genetic tilt toward low HDL means your body has been doing this cleanup less efficiently your entire life, which compounds over decades.

Metabolic Syndrome and Diabetes

Low HDL rarely travels alone. It tends to cluster with high triglycerides, abdominal fat, and insulin resistance, a constellation known as metabolic syndrome. A Korean study of over 70,000 people found that a genetic score predisposing to higher BMI also raised the risk of low HDL, roughly doubling obesity risk and modestly raising the chance of clinically low HDL.

The genetic signal also extends to type 2 diabetes. Polygenic scores for the TG to HDL ratio (a marker of insulin resistance) have been linked to higher rates of diabetes, fatty liver disease (a condition where extra fat builds up in liver cells), high blood pressure, and ischemic heart disease.

Infection and Sepsis

HDL does more than carry cholesterol. It also neutralizes bacterial toxins as part of your innate immune defense. In the UK Biobank, a genetic profile predicting higher HDL was associated with lower risk of hospitalization for infection and better 28-day survival after sepsis. Conversely, gain-of-function variants in the CETP gene that lower HDL have been linked to higher mortality during sepsis.

One large hospital cohort of 73,406 patients found that low measured HDL tracked with worse sepsis outcomes, though the HDL PRS itself was not associated with sepsis risk in that analysis. The genetic protection signal is real but inconsistent across studies, which is why this remains an active research area rather than a definitive clinical use case.

Why This Is Not Destiny

High genetic risk for low HDL does not lock in your future. Studies show that diet and lifestyle interact strongly with these inherited variants. In one Korean study of over 58,000 adults, a 4-variant HDL PRS was associated with substantially higher odds of having clinically low HDL, but the effect was modified by energy intake, smoking status, dietary glycemic index, and the makeup of gut-bacteria-feeding foods in the diet.

Another Korean analysis of 8,314 adults found that among people with high genetic risk for low HDL, a lower-carbohydrate eating pattern was linked to a significantly lower prevalence of clinically low HDL. The takeaway: high genetic risk amplifies the cost of poor habits and the payoff of good ones, rather than making lifestyle pointless.

A Counterintuitive Note on Very High HDL

HDL is often called the 'good cholesterol,' which makes 'low is bad' feel like the whole story. It is not. Extremely high HDL has been linked, in some populations, to higher all-cause mortality. The takeaway for interpreting any HDL-related test, including a PRS, is to think in terms of patterns rather than 'higher is always better.' This score is about identifying people whose HDL system runs leaner than average, where adding good habits and removing bad ones matters most.

Tracking Your Trend

Your polygenic risk score does not change over time. You are born with your variants, and they stay with you. That is actually a feature for testing: you only need to do this once, and the result stays valid for life.

What does change is the lab science around interpreting your score. Polygenic risk scores have been refined repeatedly over the past decade, and they will continue to improve, especially for non-European ancestries where current scores perform less well. Keeping your raw genetic data on file means you can rerun newer, better scores as they become available without paying for another sample.

The trend that does matter is your measured HDL on a standard lipid panel. Once you know your inherited risk, retest your actual lipids every 6 to 12 months, especially if you are making diet or exercise changes. The PRS sets context for those numbers: a person with high genetic risk who has hit a 'normal' HDL through hard work has done more biological work than someone whose HDL runs high naturally.

Decision Pathway for a High-Risk Score

A high Low HDL PRS is not a diagnosis. It is an early signal that calls for a fuller workup. The reasonable next steps are to pair this result with a complete lipid panel including ApoB (a measure of how many atherogenic particles you have, regardless of how much cholesterol each carries), triglycerides, and fasting glucose or HbA1c (a measure of average blood sugar over the past three months) to see whether the genetic risk has already begun showing up biologically.

If multiple markers point in a worrying direction (low HDL plus high triglycerides plus borderline blood sugar, for example), that pattern of metabolic syndrome warrants more aggressive lifestyle work and a conversation with a lipidologist or preventive cardiologist about whether to consider additional testing such as a coronary artery calcium scan or advanced lipoprotein analysis. If standard labs look clean despite a high PRS, the score becomes a reason to stay vigilant with serial testing rather than a reason to start treatment.

When Results Can Be Misleading

Polygenic risk scores have real limitations that affect how you should weigh them.

• Ancestry mismatch: most polygenic scores were built using data from people of European ancestry, and they perform less accurately in people of African, East Asian, South Asian, and Indigenous backgrounds. If your ancestry is not predominantly European, your score may underestimate or overestimate your true inherited risk.
• Limited overall accuracy: even at their best, current PRS explain only a modest fraction of who develops disease. A 'low' genetic risk score does not mean you are safe, and a 'high' score does not mean disease is certain. The score is one piece of a larger picture, not a verdict.
• Not a substitute for measured lipids: your actual HDL, ApoB, and other lab markers reflect what is happening in your body right now. A normal HDL on a lipid panel does not mean your PRS is normal, and a high PRS does not mean your current HDL is low. They answer different questions.
• Score versions change: different labs and research groups use different sets of variants. Two PRS reports for the same person can put you in different risk categories. The trend across reports is more useful than any single percentile.